Red: I do believe the Lympro data and announcement
Post# of 30028
Revenue is what moves a stock, but before revenue comes sales. Hopefully Gerald will be able to communicate to us soon how the sales are going. There probably aren't that many new clinical trials starting every month, so AMBS probably has a pretty good handle on each of them.